INSR and Glucose intolerance: Many more tissue-targeted insulin receptor–deficient models followed, including a β-cell–targeted insulin receptor–deficient model, which showed an insulin secretory defect (106), a liver-targeted model, which showed severe glucose intolerance (107), and an adipose tissue–selective insulin receptor knockout, which exhibited reduced fat mass and increased longevity (108).